면역조직화학 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종 용도별, 지역별 - 산업 예측(2026-2033년)

Global Immunohistochemistry Market size was valued at USD 2.9 Billion in 2024 and is poised to grow from USD 3.11 Billion in 2025 to USD 5.51 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global immunohistochemistry market is experiencing significant growth driven by the rising adoption of automation and machine learning technologies, along with the emergence of advanced IHC solutions. Enhanced protocols have led to greater reliance on IHC for accurate disease diagnosis, contributing to its escalating demand. As healthcare providers seek more efficient and reliable diagnostic tools, the integration of innovative technologies in immunohistochemistry is poised to reshape the landscape, offering improved accuracy and efficiency in pathology. The combination of these factors positions the market for considerable expansion, reflecting an increasing focus on precision diagnostics and personalized medicine in the healthcare sector. This momentum underscores a strategic shift towards technologically sophisticated approaches in immunohistochemical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segments Analysis

Global Immunohistochemistry Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Antibodies, Equipment, Reagents and Kits. Based on Application, the market is segmented into Diagnostics, Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus and Nephrological Diseases. Based on End Use, the market is segmented into Hospitals & Laboratories and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Immunohistochemistry Market

One of the key market drivers for the global immunohistochemistry market is the rising prevalence of chronic diseases, such as cancer and cardiovascular disorders, which necessitate advanced diagnostic techniques for early detection and personalized treatment options. As healthcare providers increasingly rely on immunohistochemistry for accurate tissue analysis and biomarker identification, the demand for sophisticated diagnostic tools continues to surge. Additionally, the growing emphasis on research and development in pathology and oncology further propels the market, as innovations in antibody production and assay technologies enhance diagnostic accuracy and efficacy, ultimately improving patient outcomes and driving market growth.

Restraints in the Global Immunohistochemistry Market

One significant market restraint for the global immunohistochemistry market is the high cost associated with advanced techniques and equipment. The intricate nature of immunohistochemistry assays requires specialized reagents, antibodies, and instrumentation, which can be prohibitively expensive for smaller laboratories and healthcare facilities, especially in developing regions. Additionally, the necessity for skilled personnel to accurately interpret results further escalates operational costs. This financial burden may limit the adoption of immunohistochemistry technologies in certain healthcare settings, consequently constraining market growth. Furthermore, budget constraints within healthcare systems could lead to prioritization of less costly diagnostic methods, reducing demand for these advanced diagnostic solutions.

Market Trends of the Global Immunohistochemistry Market

The global immunohistochemistry (IHC) market is witnessing a significant transformation driven by the integration of artificial intelligence and digital pathology. This technological advancement enhances the automation of image analysis workflows, thereby improving the reliability and reproducibility of diagnostic processes. AI-powered platforms are enabling more precise quantification and the identification of subtle morphological traits, while also facilitating remote histological evaluations. This shift towards data-driven diagnostics not only optimizes data management but also fosters collaborative practices among healthcare institutions. As AI-assisted methodologies gain traction in clinical settings, they are becoming pivotal in redefining the landscape of diagnostic pathology.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Immunohistochemistry Market Size by Product & CAGR (2026-2033)

• Market Overview
• Antibodies
• Equipment
• Reagents
• Kits

Global Immunohistochemistry Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Cancer
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Diabetes Mellitus
• Nephrological Diseases

Global Immunohistochemistry Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals & Laboratories
• Research Institutes

Global Immunohistochemistry Market Size & CAGR (2026-2033)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek USA, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dako (a subsidiary of Agilent Technologies)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich (part of Merck KGaA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Idec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations